These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27769299)

  • 21. Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
    Kunkel A; White M; Piola P
    PLoS Comput Biol; 2021 Mar; 17(3):e1008850. PubMed ID: 33764971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimizing the HRP-2 in vitro malaria drug susceptibility assay using a reference clone to improve comparisons of Plasmodium falciparum field isolates.
    Rutvisuttinunt W; Chaorattanakawee S; Tyner SD; Teja-Isavadharm P; Se Y; Yingyuen K; Chaichana P; Bethell D; Walsh DS; Lon C; Fukuda M; Socheat D; Noedl H; Schaecher K; Saunders DL
    Malar J; 2012 Sep; 11():325. PubMed ID: 22974086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
    Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
    Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro sensitivity of Plasmodium falciparum to artesunate in Thailand.
    Wongsrichanalai C; Wimonwattrawatee T; Sookto P; Laoboonchai A; Heppner DG; Kyle DE; Wernsdorfer WH
    Bull World Health Organ; 1999; 77(5):392-8. PubMed ID: 10361756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs.
    Wakoli DM; Ondigo BN; Ochora DO; Amwoma JG; Okore W; Mwakio EW; Chemwor G; Juma J; Okoth R; Okudo C; Yeda R; Opot BH; Cheruiyot AC; Juma D; Roth A; Ogutu BR; Boudreaux D; Andagalu B; Akala HM
    BMC Med; 2022 Nov; 20(1):448. PubMed ID: 36397090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of candidate markers and in vitro susceptibility of Plasmodium falciparum isolates from Thai-Myanmar border in relation to clinical response to artesunate-mefloquine combination.
    Phompradit P; Muhamad P; Chaijaroenkul W; Na-Bangchang K
    Acta Trop; 2014 Nov; 139():77-83. PubMed ID: 25004442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.
    Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T
    Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the
    Mungthin M; Watanatanasup E; Sitthichot N; Suwandittakul N; Khositnithikul R; Ward SA
    Am J Trop Med Hyg; 2017 Mar; 96(3):624-629. PubMed ID: 28044042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.
    Lanteri CA; Chaorattanakawee S; Lon C; Saunders DL; Rutvisuttinunt W; Yingyuen K; Bathurst I; Ding XC; Tyner SD
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5831-40. PubMed ID: 25049252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring ex vivo drug susceptibility in Plasmodium vivax isolates from Cambodia.
    Chaorattanakawee S; Lon C; Chann S; Thay KH; Kong N; You Y; Sundrakes S; Thamnurak C; Chattrakarn S; Praditpol C; Yingyuen K; Wojnarski M; Huy R; Spring MD; Walsh DS; Patel JC; Lin J; Juliano JJ; Lanteri CA; Saunders DL
    Malar J; 2017 Sep; 16(1):392. PubMed ID: 28964258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
    Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
    Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Artemisinin resistance containment project in Thailand. II: Responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia.
    Satimai W; Sudathip P; Vijaykadga S; Khamsiriwatchara A; Sawang S; Potithavoranan T; Sangvichean A; Delacollette C; Singhasivanon P; Kaewkungwal J; Lawpoolsri S
    Malar J; 2012 Aug; 11():300. PubMed ID: 22929621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delayed parasite clearance after treatment with dihydroartemisinin-piperaquine in Plasmodium falciparum malaria patients in central Vietnam.
    Thriemer K; Hong NV; Rosanas-Urgell A; Phuc BQ; Ha do M; Pockele E; Guetens P; Van NV; Duong TT; Amambua-Ngwa A; D'Alessandro U; Erhart A
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7049-55. PubMed ID: 25224002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007.
    Lim P; Wongsrichanalai C; Chim P; Khim N; Kim S; Chy S; Sem R; Nhem S; Yi P; Duong S; Bouth DM; Genton B; Beck HP; Gobert JG; Rogers WO; Coppee JY; Fandeur T; Mercereau-Puijalon O; Ringwald P; Le Bras J; Ariey F
    Antimicrob Agents Chemother; 2010 May; 54(5):2135-42. PubMed ID: 20194689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inactivation of Plasmepsins 2 and 3 Sensitizes Plasmodium falciparum to the Antimalarial Drug Piperaquine.
    Mukherjee A; Gagnon D; Wirth DF; Richard D
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquine.
    Lim P; Dek D; Try V; Sreng S; Suon S; Fairhurst RM
    Antimicrob Agents Chemother; 2015 May; 59(5):2934-7. PubMed ID: 25712365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.